)
)
Matinas BioPharma Investor Relations Material
Latest events
Q2 2024
Matinas BioPharma
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Matinas BioPharma Holdings Inc
Access all reports
Matinas BioPharma Holdings Inc. is a biopharmaceutical company focused on developing lipid nanocrystal (LNC) delivery technology for the oral delivery of small molecules, gene therapies, and vaccines. The company's proprietary LNC platform aims to enhance the absorption and bioavailability of drugs, particularly those used to treat infectious diseases and cardiovascular conditions. The company is headquartered in Bedminster, New Jersey, and its shares are listed on the NYSE.
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
MTNB
Country
🇺🇸 United States